Skip to main content

Advertisement

Log in

Palliative Stenting With or Without Radiotherapy for Inoperable Esophageal Carcinoma: A Randomized Trial

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Background

A majority of patients with esophageal cancer present with inoperable disease and require rapid and long-lasting palliation of dysphagia.

Study aim

To compare the duration of relief of dysphagia in patients with inoperable esophageal cancer treated with esophageal stenting alone or a combination of esophageal stenting and external beam radiotherapy (EBRT), and to assess overall survival, treatment-related complications, and quality of life (QOL) in the two groups.

Patients and methods

Patients with inoperable esophageal cancer and with high grade dysphagia were randomized to receive esophageal stenting with self-expandable metal stent (Ultraflex) alone (Group I), versus a combination of stenting followed by EBRT (30 gray in ten divided fractions over 2 weeks) (Group II). Dysphagia relief, overall survival, QOL (using European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30, version 3), and treatment-related complications were assessed in the two groups.

Results

From April 2007 to March 2009, 84 patients were randomized to receive esophageal stent alone (42 patients) or a combination of stent and EBRT (42 patients). The two groups were comparable in demographics, tumor characteristics, indications for palliative treatment, and pretreatment dysphagia score. Dysphagia scores improved significantly in both groups following stent insertion. However, dysphagia relief was more sustained in Group II than in Group I (7 vs. 3 months, p = 0.002). Overall median survival was significantly higher in Group II than in Group I (180 vs. 120 days, p = 0.009). Addition of radiotherapy following stenting prolonged the mean dysphagia-free survival (118.6 ± 55.8 vs. 96.8 ± 43.0 days, p = 0.054). There was significant improvement in all QOL parameters at 1 week after stenting. The QOL, however, significantly declined immediately after radiotherapy. There was no treatment-related mortality, and the incidence of complications was similar in the two groups.

Conclusion

Post-stenting EBRT effectively prolongs duration of dysphagia relief and improves overall survival in inoperable esophageal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sreedharan A, Harris K, Crellin A, Forman D, Everett SM. Interventions for dysphagia in esophageal cancer. Cochrane Database Syst Rev. 2009;(4):CD005048.

  2. Watkinson AF, Ellul J, Entwinsle K, Mason RC, Adam A. Esophageal carcinoma: initial results of palliative treatment with covered self-expanding endoprostheses. Radiology. 1995;195:821–7.

    PubMed  CAS  Google Scholar 

  3. Bown SG. Palliation of malignant dysphagia: surgery, radiotherapy, laser, intubation alone or in combination? Gut. 1991;32(8):841–4.

    Article  PubMed  CAS  Google Scholar 

  4. Ogilvie AL, Dronfield MW, Ferguson R, Atkinson M. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut. 1982;23(12):1060–7.

    Article  PubMed  CAS  Google Scholar 

  5. Song HY, Lee DH, Seo TS, et al. Retrievable covered nitinol stents: experiences in 108 patients with malignant esophageal strictures. J Vasc Interv Radiol. 2002;13(3):285–93.

    Article  PubMed  Google Scholar 

  6. Zhong J, Wu Y, Xu Z, Liu X, Xu B, Zhai Z. Treatment of medium and late stage esophageal carcinoma with combined endoscopic metal stenting and radiotherapy. Chin Med J. 2003;116(1):24–8.

    PubMed  Google Scholar 

  7. Han YT, Peng L, Fang Q, Li Q. Value of radiotherapy and chemotherapy after SEMS implantation operation in patients with malignant esophageal stricture. Ai Zheng. 2004;23(6):682–4.

    PubMed  Google Scholar 

  8. Yu YT, Yang G, Liu Y, et al. Clinical evaluation of radiotherapy for advanced esophageal cancer after metallic stent placement. World J Gastroenterol. 2004;10(14):2145–6.

    PubMed  Google Scholar 

  9. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.

    Article  PubMed  CAS  Google Scholar 

  10. Mellow MH, Pinkas H. Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction: analysis of technical and functional efficacy. Arch Intern Med. 1995;145:1443–6.

    Article  Google Scholar 

  11. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.

    Article  PubMed  CAS  Google Scholar 

  12. Dua KS. Stents for palliating malignant dysphagia and fistula: is the paradigm shifting? Gastrointest Endosc. 2007;65(1):77–81.

    Article  PubMed  Google Scholar 

  13. Homann N, Noftz MR, Klingenberg-Noftz RD, Ludwig D. Delayed complications after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate. Dig Dis Sci. 2008;53(2):334–40.

    Article  PubMed  Google Scholar 

  14. Pearson JG. The present status and future potential of radiotherapy in the management of esophageal cancer. In: Silber F, editor. Carcinoma of the esophagus. Cancer 1977;39(2 Suppl):882–90.

  15. Siersema PD, Hop WC, van Blankenstein M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective randomized study. Gastrointest Endosc. 2001;54(2):145–53.

    Article  PubMed  CAS  Google Scholar 

  16. Homs MY, Steyerberg EW, Eijkenboom WM, et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from esophageal cancer: multicentre randomized trial. Lancet. 2004;364(9444):1497–504.

    Article  PubMed  Google Scholar 

  17. Conio M, Repici A, Battaglia G, et al. A randomized prospective comparison of self-expanding plastic stents and partially covered self-expanding metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol. 2007;102(12):2667–77.

    Article  PubMed  Google Scholar 

  18. Ludwig D, Dehne A, Burmester E, et al. Treatment of unresectable carcinoma of the esophagus or the gastroesophageal junction by mesh stents with or without radiochemotherapy. Int J Oncol. 1998;13(3):583–8.

    PubMed  CAS  Google Scholar 

  19. Schmid EU, Alberts AS, Greeff F, et al. The value of radiotherapy or chemotherapy after intubation for advanced esophageal carcinoma—a prospective randomized trial. Radiother Oncol. 1993;28(1):27–30.

    Article  PubMed  CAS  Google Scholar 

  20. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20(5):1167–74.

    Article  PubMed  CAS  Google Scholar 

  21. Alberts AS, Burger W, Greeff F, et al. Severe complications of 5-fluorouracil and cisplatin with concomitant radiotherapy in inoperable non-metastatic squamous cell oesophageal cancer after intubation—early termination of a prospective randomised trial. Eur J Cancer. 1992;28:1005–6.

    Article  Google Scholar 

  22. Nishimura Y, Nagata K, Katano S, et al. Severe complications in advanced esophageal cancer treated with radiotherapy after intubation of esophageal stents: a questionnaire survey of the Japanese Society for Esophageal Diseases. Int J Radiat Oncol Biol Phys. 2003;56:1327–32.

    Article  PubMed  Google Scholar 

  23. O’Hanlon DM, Callanan K, Karat D, et al. Outcome, survival, and costs in patients undergoing intubation for carcinoma of the esophagus. Am J Surg. 1997;174(3):316–9.

    Article  PubMed  Google Scholar 

  24. Madhusudan C, Saluja SS, Pal S, et al. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life. Dis Esophagus. 2009;22(4):331–6.

    Article  Google Scholar 

  25. Maroju NK, Anbalagan P, Kate V, et al. Improvement in dysphagia and quality of life with self-expanding metallic stents in malignant esophageal strictures. Indian J Gastroenterol. 2006;25(2):62–5.

    PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by All India Institute of Medical Sciences, New Delhi, India. No financial grants or other funding was received for this study. None of the authors has any industrial links or affiliations. No other colleagues or institutes apart from the authors have contributed to the study.

Source of funding for research and publication

All India Institute of Medical Sciences, New Delhi, India.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amit Javed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Javed, A., Pal, S., Dash, N.R. et al. Palliative Stenting With or Without Radiotherapy for Inoperable Esophageal Carcinoma: A Randomized Trial. J Gastrointest Canc 43, 63–69 (2012). https://doi.org/10.1007/s12029-010-9206-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-010-9206-4

Keywords

Navigation